|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 28, 2022 09:46AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 28, 2022 10:01AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 28, 2022 10:39AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 28, 2022 12:25PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 28, 2022 02:58PM
|
|
Re: Was checking out SEDAR...
|
4
|
Zenith Epigenetics
|
Mar 28, 2022 03:48PM
|
|
Re: Covid China
|
8
|
Resverlogix Corp.
|
Mar 29, 2022 07:13PM
|
|
Re: RVX- Exempt Distribution
|
4
|
Resverlogix Corp.
|
Apr 01, 2022 11:23AM
|
|
Re: RVX- Exempt Distribution
|
4
|
Resverlogix Corp.
|
Apr 01, 2022 11:46AM
|
|
Re: Self Financing
|
2
|
Resverlogix Corp.
|
Apr 02, 2022 09:49AM
|
|
Re: Debt
|
1
|
Zenith Epigenetics
|
Apr 07, 2022 12:40PM
|
|
Re: COVID 19 / varients
|
5
|
Resverlogix Corp.
|
Apr 10, 2022 08:45PM
|
|
Re: COVID 19 / varients
|
7
|
Resverlogix Corp.
|
Apr 10, 2022 08:58PM
|
|
Re: COVID 19 / varients
|
3
|
Resverlogix Corp.
|
Apr 11, 2022 10:12AM
|
|
Hepalink continues to set new 52 week lows..
|
5
|
Resverlogix Corp.
|
Apr 11, 2022 10:51AM
|
|
Re: COVID 19 / varients
|
6
|
Resverlogix Corp.
|
Apr 11, 2022 02:19PM
|
|
Re: Veru vs Resverlogix
|
8
|
Resverlogix Corp.
|
Apr 14, 2022 01:39PM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 18, 2022 11:21AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 18, 2022 01:28PM
|
|
Re: Exempt Distribution - 2022-04-14
|
8
|
Resverlogix Corp.
|
Apr 19, 2022 11:23AM
|
